- Home
- WWW vs ELVN Comparison
WWW vs ELVN Comparison
Compare WWW & ELVN Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- WWW
- ELVN
- Stock Information
- Founded
- WWW 1883
- ELVN 2016
- Country
- WWW United States
- ELVN United States
- Employees
- WWW N/A
- ELVN N/A
- Industry
- WWW Shoe Manufacturing
- ELVN Biotechnology: Pharmaceutical Preparations
- Sector
- WWW Consumer Discretionary
- ELVN Health Care
- Exchange
- WWW Nasdaq
- ELVN Nasdaq
- Market Cap
- WWW 1.0B
- ELVN 1.2B
- IPO Year
- WWW N/A
- ELVN 2020
- Fundamental
- Price
- WWW $23.24
- ELVN $21.20
- Analyst Decision
- WWW Buy
- ELVN Strong Buy
- Analyst Count
- WWW 6
- ELVN 5
- Target Price
- WWW $19.33
- ELVN $41.20
- AVG Volume (30 Days)
- WWW 1.4M
- ELVN 520.5K
- Earning Date
- WWW 08-06-2025
- ELVN 08-12-2025
- Dividend Yield
- WWW 1.71%
- ELVN N/A
- EPS Growth
- WWW N/A
- ELVN N/A
- EPS
- WWW 0.90
- ELVN N/A
- Revenue
- WWW $1,772,400,000.00
- ELVN N/A
- Revenue This Year
- WWW $4.96
- ELVN N/A
- Revenue Next Year
- WWW $5.48
- ELVN N/A
- P/E Ratio
- WWW $26.13
- ELVN N/A
- Revenue Growth
- WWW N/A
- ELVN N/A
- 52 Week Low
- WWW $9.58
- ELVN $13.30
- 52 Week High
- WWW $24.64
- ELVN $30.03
- Technical
- Relative Strength Index (RSI)
- WWW 77.56
- ELVN 49.05
- Support Level
- WWW $18.87
- ELVN $21.25
- Resistance Level
- WWW $19.93
- ELVN $22.83
- Average True Range (ATR)
- WWW 0.75
- ELVN 1.51
- MACD
- WWW 0.33
- ELVN -0.10
- Stochastic Oscillator
- WWW 90.10
- ELVN 36.40
About WWW Wolverine World Wide Inc.
Wolverine World Wide Inc is engaged in designing, manufacturing, sourcing, marketing, licensing, and distributing branded footwear, apparel, and accessories. The company's segment includes Active Group; Work Group; Corporate and Other. It generates maximum revenue from the Active Group segment. Active Group segment consists of Merrell footwear and apparel, Saucony footwear and apparel, Sweaty Betty activewear, and Chaco footwear.
About ELVN Enliven Therapeutics Inc.
Enliven Therapeutics Inc is a clinical-stage biopharmaceutical company focused on the discovery and development of small molecule therapeutics. Its product candidates include ELVN-001 is designed to specifically target the BCR-ABL fusion gene product, the oncogenic driver for patients with chronic myeloid leukemia (CML), ELVN-002 is designed to inhibit wild-type HER2 and key mutations of HER2.